A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KUMAR ARUN; KUMAR SANDEEP; Nanda Arun

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Advanced Pharmaceutical Bulletin Year:2018 | Volume:8 | Issue:3 Page(s): 355-362

Download Full-Text

View:

372

Download:

175

Cites:

Information Journal Paper

Title

A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals

Author(s)

KUMAR ARUN | KUMAR SANDEEP | Nanda Arun | Issue Writer Certificate

Keywords

Pharmaceutical Co-crystals

Crystal Engineering

Regulatory guidelines

Patents

Abstract

Pharmaceutical Co-crystals are not new, they have gained much attention since the last decade among scientists and pharmaceutical industry. Pharmaceutical Co-crystals are multicomponent systems composed of two or more molecules and held together by noncovalent interactions. The development of Pharmaceutical Co-crystals, a new solid crystalline form, offer superior physico-chemical properties (such as melting point, stability, solubility, permeability, bioavailability, taste masking, etc. ) without altering the pharmacological properties. Recently, with the upsurge in the growth of Pharmaceutical cocrystals, the major concern is over the regulatory status of co-crystals. With the new guidelines from United States Food and Drug Administration (USFDA) and European Medicines Agency (EMA), the status has become even more complicated due to significantly different opinions. This review highlights whether co-crystals fulfil the requirements for the grant of a patent or not and how cocrystals are going to affect the present scenario of pharmaceuticals.

Cites

No record.

References

No record.

Cite

APA: Copy

KUMAR, ARUN, KUMAR, SANDEEP, & Nanda, Arun. (2018). A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals. ADVANCED PHARMACEUTICAL BULLETIN, 8(3), 355-362. SID. https://sid.ir/paper/748198/en

Vancouver: Copy

KUMAR ARUN, KUMAR SANDEEP, Nanda Arun. A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals. ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2018;8(3):355-362. Available from: https://sid.ir/paper/748198/en

IEEE: Copy

ARUN KUMAR, SANDEEP KUMAR, and Arun Nanda, “A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals,” ADVANCED PHARMACEUTICAL BULLETIN, vol. 8, no. 3, pp. 355–362, 2018, [Online]. Available: https://sid.ir/paper/748198/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops